How Tea Consumption Interacts with Genetics to Affect Cardiovascular Biomarkers in Older Adults? Findings from the

Jiali Wang1, Kaisy Xinhong Ye2, Changjiang Li1

  • 1Shandong Second Medical University.

Research Square
|November 24, 2025
PubMed

Insights

Tea consumption impacts cardiovascular biomarkers in older adults, with both beneficial and harmful effects. Genetic variants modify these effects on lipid and inflammatory markers, influencing cardiovascular disease risk.

Area of Science:

  • Gerontology
  • Cardiovascular Medicine
  • Nutrigenomics

Background:

  • Cardiovascular disease (CVD) is a leading global cause of mortality.
  • Tea is a widely consumed beverage with potential health impacts.
  • Understanding tea's effect on CVD biomarkers, especially in older adults, is crucial.

Purpose of the Study:

  • To examine the association between tea consumption and CVD biomarkers in older adults.
  • To investigate how genetic variants modify the relationship between tea consumption and CVD biomarkers.
  • To analyze the interactive effect of tea consumption and genetics on cardiovascular health indicators.

Main Methods:

  • Prospective cohort study using four waves of the Chinese Longitudinal Healthy Longevity Survey (CLHLS).
  • Analysis of older adults (65-105 years) using questionnaires and blood biochemical tests for biomarkers (e.g., Total Cholesterol, Triglycerides, HDL, LDL, hs-CRP).
  • Polygenic Risk Scores (PRS) were calculated to assess genetic influence; Generalized Estimating Equations (GEE) were used for analysis.

Main Results:

  • Tea consumption was linked to higher Total Cholesterol, Triglycerides, and LDL, and lower HDL.
  • Tea intake showed age-specific effects on High-sensitivity C-reactive protein (hs-CRP).
  • In individuals with higher PRS, tea increased Triglycerides and LDL but decreased HDL and hs-CRP.

Conclusions:

  • Tea consumption exhibits dual effects on cardiovascular biomarkers in older adults.
  • It offers protection against inflammatory markers but negatively impacts lipid metabolism.
  • Genetic variants significantly modify these effects, highlighting a nutrigenomic interaction in CVD risk.
Abstract

Related Concept Videos

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism

Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
186
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
180
Human Genetics01:28

Human Genetics

Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
1.4K
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
769
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution01:00

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution

Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
217
Longitudinal Research02:20

Longitudinal Research

Sometimes we want to see how people change over time, as in studies of human development and lifespan. When we test the same group of individuals repeatedly over an extended period of time, we are conducting longitudinal research. Longitudinal research is a research design in which data-gathering is administered repeatedly over an extended period of time. For example, we may survey a group of individuals about their dietary habits at age 20, retest them a decade later at age 30, and then again...
13.0K